FDA issued a Warning Letter to Mylan Pharmaceuticals Inc. on 11/9/2018 as a result of this inspection.
483 Mylan Pharmaceuticals Apr 2018

483 Mylan Pharmaceuticals Apr 2018

Atul Agrawal FDA, Ileana Barreto-Pettit FDA, Rebecca Dombrowski FDA, James Mason FDA, Ko Min FDA, Marcus Ray FDA, Melissa Roy FDA, Alison Stieg FDA$119.00 - Available Now

FDA investigators audited the Mylan Pharmaceuticals - Morgantown, WV, United States facility and issued inspectional observations (via FDA 483) on 12 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Apr 2018
  • Location: Morgantown, United States
  • FEI: 1110315
Add To Cart